摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-hydroxy-4-[({4-[(2-methyl-4-quinolinyl)methoxy]benzoyl}amino)methyl]-1-propyl-4-piperidinecarboxamide

中文名称
——
中文别名
——
英文名称
N-hydroxy-4-[({4-[(2-methyl-4-quinolinyl)methoxy]benzoyl}amino)methyl]-1-propyl-4-piperidinecarboxamide
英文别名
N-hydroxy-4-((4-((2-methylquinolin-4-yl)methoxy)benzamido)methyl)-1-propylpiperidine-4-carboxamide;N-hydroxy-4-[[[4-[(2-methylquinolin-4-yl)methoxy]benzoyl]amino]methyl]-1-propylpiperidine-4-carboxamide
N-hydroxy-4-[({4-[(2-methyl-4-quinolinyl)methoxy]benzoyl}amino)methyl]-1-propyl-4-piperidinecarboxamide化学式
CAS
——
化学式
C28H34N4O4
mdl
——
分子量
490.602
InChiKey
GTCRWKBEGBSXDD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.4
  • 重原子数:
    36
  • 可旋转键数:
    9
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.39
  • 拓扑面积:
    104
  • 氢给体数:
    3
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Beta-Amino-Acid derivatives as inhibitors of matrix metalloproteases and TNF-Alpha
    申请人:——
    公开号:US20020013341A1
    公开(公告)日:2002-01-31
    The present application describes novel &bgr;-amino acid derivatives of formula I: 1 or pharmaceutically acceptable salt or prodrug forms thereof, wherein A, X, Z, U a , X a , Y a , Z a , R 1 , R 2 , R 3 , R 4 , and R 4a are defined in the present specification, which are useful as metalloprotease and/or as TNF-&agr; inhibitors.
    本申请描述了式I的新型β-氨基酸衍生物: 1 或其药用可接受的盐或前药形式,其中A、X、Z、U a 、X a 、Y a 、Z a 、R 1 、R 2 、R 3 、R 4 和R 4a 在本规范中有定义,这些衍生物可用作金属蛋白酶和/或TNF-α抑制剂。
  • Beta-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-alpha
    申请人:——
    公开号:US20040072802A1
    公开(公告)日:2004-04-15
    The present application describes novel &bgr;-amino acid derivatives of formula I: 1 or pharmaceutically acceptable salt or prodrug forms thereof, wherein A, X, Z, U a , X a , Y a , Z a , R 1 , R 2 , R 3 , R 4 , and R 4a are defined in the present specification, which are useful as metalloprotease and/or as TNF-&agr; inhibitors.
    本申请描述了式I的新颖β-氨基酸衍生物:1或其药用可接受的盐或前药形式,其中A、X、Z、Ua、Xa、Ya、Za、R1、R2、R3、R4和R4a在本规范中有定义,这些衍生物可用作金属蛋白酶和/或TNF-α抑制剂。
  • BETA-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEASES AND TNF-ALPHA
    申请人:Bristol-Myers Squibb Pharma Company
    公开号:EP1263756B1
    公开(公告)日:2004-02-25
  • US6495565B2
    申请人:——
    公开号:US6495565B2
    公开(公告)日:2002-12-17
  • Synthesis and structure–activity relationship of a novel, achiral series of TNF-α converting enzyme inhibitors
    作者:John L. Gilmore、Bryan W. King、Cathy Harris、Thomas Maduskuie、Stephen E. Mercer、Rui-Qin Liu、Maryanne B. Covington、Mingxin Qian、Maria D. Ribadeneria、Krishna Vaddi、James M. Trzaskos、Robert C. Newton、Carl P. Decicco、James J.-W. Duan
    DOI:10.1016/j.bmcl.2006.02.015
    日期:2006.5
    A novel series of achiral TNF-alpha converting enzyme (TACE) inhibitors has been discovered. These compounds exhibited activities from 0.35 to 11 nM in a porcine TACE assay and inhibited TNF-alpha production in an LPS-stimulated whole blood assay with an IC50 value of 23 nM for the most potent one. They also have excellent selectivities over related metalloproteases including aggrecanases. (C) 2006 Elsevier Ltd. All rights reserved.
查看更多